First Tracks Biotherapeutics TRAX Income Statement (2024-2026)

NASDAQ TRAX
$46.56 -0.54 (-1.15%)
At close: Nov 16, 2026 · 4:00 PM EST
Reported Financials

First Tracks Biotherapeutics Quarterly Income Statement

Periods 8 quarters
Latest Sep 2026

First Tracks Biotherapeutics reported net income of -$31.36M for the quarter ended Sep 2026. This income statement covers 8 quarters of results from Dec 2024 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating items
Research & DevelopmentR&D 41.47M39.27M33.32M25.56M33.96M25.64M23.85M
Selling, General & AdministrativeSG&A 9.82M6.63M11.74M11.22M18.86M9.29M9.00M
Other Operating ExpensesOther Opex 4.08M2.33M
Operating ExpensesOpex 51.28M45.90M45.06M36.77M52.81M34.94M32.84M
Operating IncomeOp. Inc -181.10M-51.28M-45.90M-45.06M-179.01M-52.81M-34.94M-32.84M
Non-operating items
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales -0.14M-0.17M0.05M-0.33M-0.12M0.15M
Interest & Investment IncomeInt & Inv Inc 4.09M3.47M3.20M2.19M2.33M1.56M1.50M
Other Non Operating IncomeOther Non Op Inc. -0.01M-0.01M0.00M0.00M0.00M-0.01M
Non Operating IncomeNon Op. Inc. 4.08M3.45M3.20M-0.02M2.33M1.56M1.49M
Net income details
EBIT -181.10M-51.28M-45.90M-45.06M-179.01M-52.81M-34.94M-32.84M
EBT -181.10M-47.19M-42.43M-41.86M-176.82M-50.48M-33.37M-31.35M
Income After Tax -181.10M-47.19M-42.43M-41.86M-176.82M-50.48M-33.37M-31.35M
Income from Continuing OperationsIncome (Continuing) -181.10M-47.19M-42.43M-41.86M-176.82M-50.48M-33.37M-31.35M
Consolidated Net IncomeConsol Net Inc. -162.60M-47.34M-42.61M-41.81M-166.42M-50.61M-33.23M-31.36M
Income towards Parent CompanyParent Net Inc -163.71M-47.20M-42.45M-41.86M-166.09M-50.48M-33.37M-31.36M
Net Income towards Common StockholdersNet Income -163.71M-47.20M-42.45M-41.86M-166.09M-50.48M-33.37M-31.36M
Additional items
EPS (Basic) -1.47-1.50-5.97-1.81-0.95-0.88
EPS (Diluted) -1.47-1.50-5.97-1.81-0.95-0.88
Shares Outstanding 28.81M27.83M27.83M27.83M35.00M35.75M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 28.81M27.83M27.83M27.83M35.00M35.75M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 28.81M27.83M35.39M35.90M
EBITDA -51.13M-45.76M-44.92M-178.88M-52.69M-34.83M-32.75M

First Tracks Biotherapeutics Income Statement API

Pull First Tracks Biotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TRAX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY